OpenAI is facing significant user backlash over the recent launch of ChatGPT Work and GPT-5.6 Sol, admitting "we didn't get everything quite right." Users reported rapid usage limit exhaustion, a confusing desktop app, and degraded multi-agent workflows, prompting OpenAI to scramble for urgent fixes to UX and cost clarity.

OpenAI introduces GPT-5.6, a groundbreaking AI model that sets new standards for intelligence and efficiency. This model achieves state-of-the-art results in various fields, outperforming previous models at lower costs. GPT-5.6 is available in three variants: Sol, Terra, and Luna, catering to different needs and budgets.

OpenAI CEO suggests that video games can be a superior training data source than the internet for achieving AGI, with significant implications for the AI industry.

OpenAI CEO Sam Altman is in talks with President Trump to give the US government a 5% stake in the company, valued at $42.6 billion. This move could provide a safety net for Americans, mitigating the impact of AI on the labor market.

OpenAI CEO Sam Altman has reportedly proposed donating 5% of the company's equity to a U.S. sovereign wealth fund. This groundbreaking move reignites crucial discussions around public participation in the immense financial gains generated by the AI boom and could set a new precedent for AI governance and wealth distribution.

A California man has sued OpenAI and CEO Sam Altman, alleging that conversations with ChatGPT exacerbated his bipolar disorder, leading to delusions and a suicide attempt. The lawsuit highlights critical questions about AI safety, mental health safeguards, and the ethical responsibilities of generative AI developers. This case is part of a growing trend of legal challenges against OpenAI concerning its model's societal impact.

OpenAI's outage led to account deactivations, causing users to lose their work and face delays in their projects.

OpenAI's latest research demonstrates how large language models can automate training data labeling for entity matching, reducing manual effort by 99% and slashing costs. This breakthrough enables faster, cheaper AI deployment for businesses.

A groundbreaking MIT study reveals how labeling AI agents as 'employees' leads to worse human oversight, as companies like OpenAI push agentic AI tools. New research shows a 18% drop in error detection when AI work is framed as coming from 'digital coworkers.'

OpenAI and Sceye lead groundbreaking advancements in AI collaboration and stratospheric internet. Discover how these innovations are reshaping workplaces and global connectivity.

Anthropic unveils Claude Sonnet 5, a groundbreaking AI model offering enhanced agentic capabilities at lower costs. Targeting developers and businesses, the model aims to outperform competitors like GPT-5.5 and Gemini Pro while reducing operational expenses.

The 246th LWiAI podcast breaks down Google’s Gemini 3.5 flash model, the multimodal Gemini Omni video engine, Elon Musk’s lost lawsuit, and OpenAI’s breakthrough on an 80‑year‑old Erdős geometry problem. We unpack the technical specs, market ripples, and what developers should watch next.

A new arXiv study shows OpenEvidence's specialized clinical tool beats top general‑purpose models (Claude Opus 4.8, Gemini 3.1 Pro, GPT‑5.5) on 620 real‑world point‑of‑care questions. Physicians across 30 specialties rated the specialized tool higher on accuracy, utility, source quality, verifiability and completeness.

OpenAI co‑founder Greg Brockman testified that the company expects to spend $50 billion on compute this year, a figure tied to massive cloud and hardware deals. The revelation spotlights the economics of large‑scale AI and raises questions about profitability and investor expectations.

OpenAI introduces ATHENA-R1, an AI agent for treatment reasoning that outperforms language models and tool-use systems. Trained on 212 biomedical tools, ATHENA-R1 achieves 94.7% accuracy on open-ended drug reasoning and 82.9% on treatment reasoning. This breakthrough has significant implications for the healthcare industry and AI research.

OpenAI introduces IMCBench, a benchmark for multimodal large language models in image-grounded medical conversations, evaluating safety, accuracy, and uncertainty in diagnosis. The benchmark tests eight models, with Claude Opus 4.6 achieving the highest overall score. The results highlight the need for multi-dimensional evaluation frameworks in medical AI.